Back to Search Start Over

Phase II trial of neoadjuvant mFOLFOX 6 with panitumumab (P) in T3 rectal cancer with clear mesorectal fascia (MRF) and KRAS, NRAS, BRAF, PI3KCA wild type (4WT). GEMCAD 1601 PIER trial

Authors :
Fernandez-Martos C
Pericay C
Maurel J
Virgili A
Capdevila J
Gallego J
Vera R
Rodriguez-Salas N
Losa F
Valladares M
Vivancos A
Ayuso J
Maas M
Martinez F
Melian M
de Albeniz X
Source :
JOURNAL OF CLINICAL ONCOLOGY, r-FISABIO. Repositorio Institucional de Producción Científica, instname
Publication Year :
2021
Publisher :
AMER SOC CLINICAL ONCOLOGY, 2021.

Details

ISSN :
0732183X
Database :
OpenAIRE
Journal :
JOURNAL OF CLINICAL ONCOLOGY, r-FISABIO. Repositorio Institucional de Producción Científica, instname
Accession number :
edsair.RECOLECTA.....40fdb31575b3507cf4aa664e3d2774ef